No price history available.
Key financial summary
Financials in SAR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | SARm | 500 | 513 | 675 | 741 | 756 | 730 | N/A | N/A |
| Operating profit | SARm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | SARm | 32 | 34 | 40 | 6 | 9 | 17 | N/A | N/A |
| EPS reported | SAR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | SAR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | SAR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | SAR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | SARm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | SARm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | SARm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | SAR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | SAR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in SAR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Basic Chemical Industries Company (BCI), founded in 1973 and based in Dammam, Saudi Arabia, operates as a key manufacturer and supplier of chemical products, primarily within the Kingdom. Its operations are structured across two main divisions: Chemicals, and Adhesives and Other Materials. BCI offers a diverse portfolio of products, including hydrochloric acid, caustic soda, chlorine gas, sodium hypochlorite, and polyurethane chemicals, alongside ferric chloride, hot and cold melt adhesives, and sulfuric acid, which serve numerous industrial applications. Beyond manufacturing, the company's activities span the full chemical supply chain, encompassing sourcing, formulation, processing, international trade (import and export), marketing, distribution, and acting as an agent for chemical sales.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Basic Chemical Industries Company (1210.SR)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Basic Chemical Industries Company (BCI), founded in 1973 and based in Dammam, Saudi Arabia, operates as a key manufacturer and supplier of chemical products, primarily within the Kingdom. Its operations are structured across two main divisions: Chemicals, and Adhesives and Other Materials. BCI offers a diverse portfolio of products, including hydrochloric acid, caustic soda, chlorine gas, sodium hypochlorite, and polyurethane chemicals, alongside ferric chloride, hot and cold melt adhesives, and sulfuric acid, which serve numerous industrial applications. Beyond manufacturing, the company's activities span the full chemical supply chain, encompassing sourcing, formulation, processing, international trade (import and export), marketing, distribution, and acting as an agent for chemical sales.